For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230209:nRSI4431Pa&default-theme=true
RNS Number : 4431P Versarien PLC 09 February 2023
9 February 2023
Versarien plc
("Versarien" or the "Company")
AIM Rule 17 Update
Versarien plc (AIM: VRS), the advanced materials engineering group, provides
the following update in accordance with its disclosure obligations required
under Rule 17 of the AIM Rules for Companies.
In a correction to the announcement of 7 January 2021, the Company advises
that Dr Stephen Hodge, Chief Technology Officer, holds a beneficial interest
in 46,774 ordinary shares of 1 pence each in the Company, acquired as part of
Versarien's acquisition of Cambridge Graphene Limited in January 2017.
For further information please contact:
Versarien Plc
Neill Ricketts - Chief Executive Officer +44 (0) 1594 887204
Chris Leigh - Chief Financial Officer
Stephen Hodge - Chief Technology Officer
SP Angel Corporate Finance (Nominated Adviser and Joint Broker)
Matthew Johnson, Adam Cowl +44 (0) 20 3470 0470
Berenberg (Joint Broker)
Mark Whitmore, Ciaran Walsh +44 (0) 20 3207 7800
IFC Advisory Limited (Financial PR and Investor Relations)
Tim Metcalfe, Zach Cohen +44 (0) 20 3934 6630
About Versarien Plc
The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised
graphene company with a wide portfolio of high-quality verified materials
allied to the largest relevant IP portfolio supported by its own UK based
research and development centre driving recurring revenue growth through its
innovative graphene product applications.
For further information please see: https://www.versarien.com
(https://www.versarien.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUKOWRORUURRR